Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1970 1
1975 1
1981 1
1989 2
1991 1
1995 1
1998 1
2002 2
2006 2
2007 1
2009 3
2010 1
2013 2
2014 1
2015 2
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Primary cerebral neuroblastoma.
Mierau GW, Timmons CF, Orsini EN, Crouse VL. Mierau GW, et al. Among authors: crouse vl. Ultrastruct Pathol. 1989 Mar-Jun;13(2-3):281-9. doi: 10.3109/01913128909057446. Ultrastruct Pathol. 1989. PMID: 2734857 No abstract available.
Mode of delivery and risk of childhood leukemia.
Francis SS, Selvin S, Metayer C, Wallace AD, Crouse V, Moore TB, Wiemels JL, Buffler PA. Francis SS, et al. Among authors: crouse v. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):876-81. doi: 10.1158/1055-9965.EPI-13-1098. Epub 2014 Mar 11. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24618997
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK; Children’s Oncology Group. Baker DL, et al. N Engl J Med. 2010 Sep 30;363(14):1313-23. doi: 10.1056/NEJMoa1001527. N Engl J Med. 2010. PMID: 20879880 Free PMC article. Clinical Trial.
Parental smoking and the risk of childhood leukemia.
Chang JS, Selvin S, Metayer C, Crouse V, Golembesky A, Buffler PA. Chang JS, et al. Among authors: crouse v. Am J Epidemiol. 2006 Jun 15;163(12):1091-100. doi: 10.1093/aje/kwj143. Epub 2006 Apr 5. Am J Epidemiol. 2006. PMID: 16597704
Response of neuroblastoma to retinoic acid in vitro and in vivo.
Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC. Reynolds CP, et al. Among authors: crouse vl. Prog Clin Biol Res. 1991;366:203-11. Prog Clin Biol Res. 1991. PMID: 2068138 No abstract available.
25 results